Article
TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
European journal of clinical pharmacology - 1 May 2009
Kurzawski Mateusz, Dziewanowski Krzysztof, Lener Agnieszka, Drozdzik Marek
Abstract excerpt
PURPOSE: Thiopurine drugs have to be withdrawn in 10-30% of cases due to side effects, and it has been presented that genetic factors may be responsible for some of reported toxicity cases. Among polymorphic enzymes of thiopurines' metabolic pathway, thiopurine S-methyltransferase (TPMT) has been studied most extensively, and some recent studies point to inosine triphosphate pyrophosphohydrolase (ITPA)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
